Association of Family History and Polygenic Risk Scores With Prostate Cancer in Africa These data should be used in ongoing efforts to improve equitable access to systemic therapies for patients with ...

ALLO-316 shows promising response rates in advanced renal cell carcinoma, utilizing Dagger technology for enhanced CAR T cell efficacy. Allogene Therapeutics has announced promising data from its ...